ARS Pharmaceuticals SPRY
NASDAQ SPRY
$3.57 +0.42 (+13.33%)
At close: Nov 10, 2026 · 4:00 PM EST

ARS Pharmaceuticals (SPRY) Shares Outstanding (Diluted) (2021 - 2026)

Updated

ARS Pharmaceuticals (SPRY) posted Weighted Average Shares Outstanding (Diluted) of 99.31 million for Q2 2026, up 1.0% from 98.36 million a year earlier and unchanged from the prior quarter.

Analysis

ARS Pharmaceuticals (SPRY) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

For FY2025, ARS Pharmaceuticals' Weighted Average Shares Outstanding (Diluted) came in at 98.57 million, down 3.7% from FY2024.

  • Annual Weighted Average Shares Outstanding (Diluted) shows a four-year compound annual growth rate of 35.9% (FY2021 to FY2025).
  • In prior years, ARS Pharmaceuticals' Weighted Average Shares Outstanding (Diluted) was 102.39 million in FY2024 (+7.5%), 95.22 million in FY2023 (+138.3%), 39.96 million in FY2022 (+38.4%) and 28.87 million in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Weighted Average Shares Outstanding (Diluted) since Q4 2024.
  • On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) increased in seven of the last eight quarters, with growth averaging 1.6%.
  • The strongest year-over-year quarter for Weighted Average Shares Outstanding (Diluted) in the past five years was Q1 2023, with growth of 210.3%; the weakest was Q4 2025, with a decline of 3.7%.
  • According to Business Quant data, Weighted Average Shares Outstanding (Diluted) for the three prior quarters was 99.3 million (Q1 2026), 98.57 million (Q4 2025) and 98.81 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 ARS Pharmaceuticals 357.89 Mn 219.49 Mn 27.61 Mn 99.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 99.69 Mn
Jun 30, 2026 99.31 Mn
Mar 31, 2026 99.30 Mn
Dec 31, 2025 98.57 Mn
Sep 30, 2025 98.81 Mn
Jun 30, 2025 98.36 Mn
Mar 31, 2025 98.06 Mn
Dec 31, 2024 102.39 Mn
Sep 30, 2024 97.03 Mn
Jun 30, 2024 96.83 Mn
Mar 31, 2024 96.49 Mn
Dec 31, 2023 95.22 Mn
Sep 30, 2023 95.58 Mn
Jun 30, 2023 94.91 Mn
Mar 31, 2023 94.23 Mn
Dec 31, 2022 39.96 Mn
Sep 30, 2022 35.46 Mn
Jun 30, 2022 30.61 Mn
Mar 31, 2022 30.37 Mn
Dec 31, 2021 28.87 Mn
API Access

ARS Pharmaceuticals Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SPRY&period=max&api_key=YOUR_API_KEY